VCF CONTRACEPTIVE

APOTHECUS PHARMACEUTICAL CORP. faces a Class II voluntary recall of 33,659 retail boxes of VCF CONTRACEPTIVE PRE-FILLED APPLICATORS (NONOXYNOL-9) due to critical CGMP deviations, specifically out-of-specification assay results. This marks a recurring compliance issue for the Hicksville, NY-based manufacturer, impacting supply chains in the USA and Hong Kong. Procurement and regulatory teams must assess immediate product availability risks and long-term supplier reliability, given the pattern of quality control failures.

Apothecus Pharmaceutical Corp. initiated a Class II recall for 17,280 cartons of VCF Vaginal Contraceptive Film (nonoxynol-9) due to cGMP deviations. This nationwide U.S. recall, D-0427-2024, highlights critical compliance gaps. For procurement and regulatory leaders, this underscores the imperative for stringent supplier qualification and robust quality oversight to mitigate supply chain disruptions and ensure product integrity.